NDC 66689-105

THYQUIDITY

Levothyroxine Sodium

THYQUIDITY is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Vistapharm, Inc.. The primary component is Levothyroxine Sodium.

Product ID66689-105_24ae0fe1-3627-4fb9-a5b7-d186aa3e01cb
NDC66689-105
Product TypeHuman Prescription Drug
Proprietary NameTHYQUIDITY
Generic NameLevothyroxine Sodium
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2021-02-15
Marketing End Date2024-07-31
Marketing CategoryNDA / NDA
Application NumberNDA214047
Labeler NameVistaPharm, Inc.
Substance NameLEVOTHYROXINE SODIUM
Active Ingredient Strength100 ug/5mL
Pharm ClassesThyroxine [CS], l-Thyroxine [EPC]
NDC Exclude FlagN

Packaging

NDC 66689-105-02

2 CARTON in 1 CARTON (66689-105-02) > 1 BOTTLE, GLASS in 1 CARTON > 100 mL in 1 BOTTLE, GLASS
Marketing Start Date2021-02-15
Marketing End Date2024-07-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "THYQUIDITY" or generic name "Levothyroxine Sodium"

NDCBrand NameGeneric Name
66689-105THYQUIDITYTHYQUIDITY
0074-3727SynthroidLevothyroxine Sodium
0074-4341SynthroidLevothyroxine Sodium
0074-4552SynthroidLevothyroxine Sodium
0074-5182SynthroidLevothyroxine Sodium
0074-6594SynthroidLevothyroxine Sodium
0074-6624SynthroidLevothyroxine Sodium
0074-7068SynthroidLevothyroxine Sodium
0074-7069SynthroidLevothyroxine Sodium

Trademark Results [THYQUIDITY]

Mark Image

Registration | Serial
Company
Trademark
Application Date
THYQUIDITY
THYQUIDITY
88945650 not registered Live/Pending
VistaPharm, Inc.
2020-06-03
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.